Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.

There was an imbalance in patient characteristics between the PC and PE groups in their study such that the PC group had more adverse prognostic characteristics including weight loss, age, and anemia, although these differences did not reach statistical significance.

also in 111,027 other papers